Early results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehensive ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Sarcoma is a rare and complex cancer that most people never ...

Phase II study to evaluate surufatinib in patients with osteosarcoma and soft tissue sarcoma that has failed standard chemotherapy: Updated analysis. This is an ASCO Meeting Abstract from the 2024 ...

The field of sarcoma study is getting more specific, with clinical investigations drilling down to more specific subtypes of soft tissue sarcoma for better targeted therapies. Our discussion with ...

A triple-drug regimen combining two immunotherapy agents with radiation before surgery appears to activate immune defenses ...

Soft tissue sarcomas are rare, aggressive cancers with complex treatment needs and high mortality, especially in metastatic cases. The study found no significant difference in median TTI between MDC ...

Liposarcoma market growth is driven by increasing awareness and earlier diagnosis, expanding the pool of treatable patients. Advances in molecular profiling and targeted therapies are attracting ...

Sarcomas are tumors that form in the body’s connective tissues such as bone, muscle and fat. They are rare and, because there are more than 150 types, patients benefit from seeing a sarcoma specialist ...